News

Summary Available! TB Clinical Trials Consultants Meeting

On November 17 and 18, a TB Clinical Trials Consultants Meeting was held at St. George’s, University of London. The meeting was organized by CDC, CPTR, INTERTB, NIH, and TB Alliance. The meeting was convened to catalog expert opinion on the conduct of Phase 2 and Phase 3 clinical trials in tuberculosis. Sessions included:

  • Session 1: Clinical aspects of Phase 2 studies measuring sputum mycobacterial load over time
  • Session 2: Laboratory aspects of Phase 2 studies measuring sputum mycobacterial load over time
  • Session 3: Analytical aspects of Phase 2 studies measuring sputum mycobacterial load over time
  • Session 4: Clinical aspects of Phase 3 studies
  • Session 5: Laboratory aspects of Phase 3 studies
  • Session 6: Analytical aspects / endpoints of Phase 3 studies

Click here to get the summary of the meeting with all the questions and answers.

More News
23 Aug 2022
Last week, the PAN-TB collaboration announced initial plans for a Phase 2 clinical trial evaluating two novel drug regimens to treat Tuberculosis. Sponsored by the Bill and Melinda Gates Foundation, the PAN-TB, or “Project to Accelerate New Treatments for Tuberculosis”, collaboration brings...
4 May 2022
Earlier this week, the World Health Organization (WHO) released a rapid communication which detailed the upcoming changes to the treatment guidance for drug-resistant tuberculosis (DR-TB). These guidelines are used to inform national TB programmes globally on how to treat patients with these...
5 Apr 2022
On April 01, 2022, the Stop TB Partnership launched the second online consultation for the new Global Plan to End TB 2023-2030. Over the years, the Global Plans have been important tools for advocacy and resource mobilization, and served as a reference document for donors and stakeholders. In May...